Treatment of HIV/AIDS patients with Glutamine Dipeptide

Not Applicable

• Conditions: HIV/AIDS; Disease caused by human immunodeficiency virus; C02.782.815.616.400.040

• Registration Number: RBR-843tnq
• Lead Sponsor: EM-Universidade Estadual de Maringá

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-09-21
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

HIV positive; both genders; between 18 and 60 years; regular use of antiretroviral therapy; good adherence to therapy; HIV viral load stable in the last 6 months

Exclusion Criteria

pregnant women; psychiatric patients; more than 60 years old; chronic kidney disease; swallowing difficulty.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The improvement of the patient is assessed by reduction in immunosuppression process and viral load by conducting laboratory measurements of cytokines and the immune status indicator cells, and HIV load.<br>

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected